Boundary Capital Partners

Boundary Capital Partners is a UK-based venture capital firm specializing in early-stage investments in technology and life sciences sectors. The firm focuses on high-growth private companies that aim to positively impact millions of lives. Their investment approach combines financial support with hands-on involvement, leveraging the team's expertise to accelerate business growth.

The firm's investment strategy encompasses a range of stages, from pre-seed to pre-IPO, with typical investments ranging from £100,000 to £1.5 million. Boundary Capital Partners has a strong emphasis on sectors such as technology, life sciences, engineering, software, and data science. They are particularly interested in companies that address critical global issues, including health, climate change, and food security.

Boundary Capital Partners is committed to impact investing, utilizing a proprietary methodology called 'Equivalent Lives Impacted' (ELI) to measure the positive impact of their investments. This approach aligns with their mission to support businesses that not only offer commercial success but also contribute to societal well-being. The firm is regulated by the UK's Financial Conduct Authority as a venture capital investor and has a history of co-investing with organizations like Innovate UK to support innovative startups.